New therapeutic frontiers in the management of achondroplasia

Government

Compuscript Ltd Apr 20 2025 A recent publication in Genes & Diseases has delivered a compelling synthesis of the latest insights into the cellular mechanisms and therapeutic interventions for achondroplasia, the most common form of genetic dwarfism. This disorder stems primarily from gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene, which exerts widespread effects on skeletal development, leading to disrupted endochondral ossification, reduced chondrocyte

New therapeutic frontiers in the management of achondroplasia https://www.news-medical.net - 20.04.2025 20:54

din zilele anterioare

New therapeutic frontiers in the management of achondroplasia https://www.news-medical.net - 20.04.2025 20:54